India Insulin Delivery Devices Market to Establish Growth Due to Rapid Technological Advancement Until FY2027
Increasing prevalence of the blood sugar diseases is
driving the growth if India Insulin Delivery Devices Market, FY2017-FY2027.
According to TechSci report on, “India Insulin
Delivery Devices Market
By
Product Type (Pens, Pumps, Pen Needles, Others) By Distribution Channel
(Hospital Pharmacies, Retail Pharmacies, Online, Others) By End User (Hospitals
& Clinics, Homecare, Others) By Region, Competition Forecast &
Opportunities, FY2027”, India
insulin delivery devices market has shown promising growth in
historical years until FY2020 and is expected to continue its growth in
upcoming forecast years FY2023 to FY2027. India insulin delivery devices market
owes its growth to the factors like surge in the number of the diabetic
patients and their demand toward the at home medical facilities including the
administration of the insulin and other diabetes controlling drugs and
monitoring their dosages. The cases of diabetes is increasing due to unhealthy
lifestyle, unhealthy food habits, and poor life choices like alcoholism and
smoking that increases the chances of high blood sugar level along with various
other generic related diseases like obesity, early aging, and loss of hair,
blood thickening etc. Moreover, the surge in the demand of the technically
advanced medical devices that have the advantage of monitoring the dosage along
with the easy administration is driving the India insulin delivery devices
market in the next five years until, FY2027.
Browse over XX market data Figures
spread through 70 Pages and an in-depth TOC on "India Insulin
Delivery Devices Market"
https://www.techsciresearch.com/report/india-insulin-delivery-devices-market/7614.html
The India insulin
delivery devices market is segmented by product type, distribution channel, and
user, competitional landscape, and regional distribution. Based on distribution
channel the market is further bifurcated into hospital pharmacies, retail
pharmacies, online, and others. Hospital pharmacies are anticipated to hold the
largest market shares on the account of high number of patients and their
continuous visitation to the physicians and experts in the hospitals. Moreover,
retail pharmacies, provide a cheaper option and branded as well as unbranded
products and patients who cannot afford the high-end medical facilities prefer
retail pharmacies over the hospital pharmacies, thus the significant growth in
the market segment in the upcoming five years.
Based on end user, the market
is further fragmented into hospitals & clinics, homecare, and others. Homecare
is anticipated to hold the largest market share in the next five years. The
market attributes can be termed with the increase in the demand of the home
care setting for the diabetic patients. Diabetes is not a disease that would
cause some immediate effect, though prolonged suffering due to diabetes causes
various cardiovascular diseases, thickening of blood, and heart attack It
becomes a condition that requires a continuous monitoring and administration of
insulin to overcome its symptoms. Medication and physical activities help, thus
staying in the hospital for a long period of time is not required. Thus, the
homecare segment is expected to grow. Experts and physicians may use glucose
monitoring devices to monitor the patient’s blood sugar level making the
regular consultation and emergency alarming situation a convenience for both
the patient and the concerned physician.
Some of the top players
in the India insulin delivery devices market are, Biocon Limited, India
Medtronic Pvt. Ltd., Roche (Products) India Pvt. Ltd., Becton Dickinson Private
Limited, Ypsomed India Private Ltd, Novo Nordisk India, Sanofi India Ltd. (Aventis
Pharma), Eli Lilly & Co (India) Pvt. Ltd, Abbott India Ltd, B. Braun
Medical (India) Pvt. Ltd., among others. The companies are involving themselves
into research and development for more advanced medical devices. Insulin
delivery devices are diagnostic imaging products and are in demand owing to the
need of the healthcare industry. New players entering the market may form
partnerships with other players or the end users of the industry for a
consistent inflow of the product.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7614
Customers can also request for 10% free customization on this report.
“Insulin delivery
devices are one of the most important therapeutic delivery devices that are
specifically designed to administer dosages of insulin to the diabetic patient.
Market players are constantly researching and developing the technologically
advanced insulin delivery devices to provide more efficient, cost-effective
devices that give feasible and monitoring advantages to the device. Government
support and private financial aids toward the research and development is also
one of the major drivers of the market. New players can focus on the investments
and on the market launches of the technologically advanced products,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“India Insulin Delivery
Devices Market By Product Type (Pens, Pumps, Pen Needles, Others) By
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others) By
End User (Hospitals & Clinics, Homecare, Others) By Region, Competition
Forecast & Opportunities, FY2027” has evaluated the future growth potential
of India Insulin Delivery Devices market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in India Insulin Delivery Devices market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/